These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

770 related articles for article (PubMed ID: 34930919)

  • 1. Finding genetically-supported drug targets for Parkinson's disease using Mendelian randomization of the druggable genome.
    Storm CS; Kia DA; Almramhi MM; Bandres-Ciga S; Finan C; ; Hingorani AD; Wood NW
    Nat Commun; 2021 Dec; 12(1):7342. PubMed ID: 34930919
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mendelian Randomization Study Using Dopaminergic Neuron-Specific eQTL Nominates Potential Causal Genes for Parkinson's Disease.
    Dang X; Zhang Z; Luo XJ
    Mov Disord; 2022 Dec; 37(12):2451-2456. PubMed ID: 36177513
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Brain Proteome-Wide and Transcriptome-Wide Asso-ciation Studies, Bayesian Colocalization, and Mendelian Randomization Analyses Reveal Causal Genes of Parkinson's Disease.
    Zhou S; Tian Y; Song X; Xiong J; Cheng G
    J Gerontol A Biol Sci Med Sci; 2023 Mar; 78(4):563-568. PubMed ID: 36511626
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mendelian randomization analysis identifies druggable genes and drugs repurposing for chronic obstructive pulmonary disease.
    Wang Z; Li S; Cai G; Gao Y; Yang H; Li Y; Liang J; Zhang S; Hu J; Zheng J
    Front Cell Infect Microbiol; 2024; 14():1386506. PubMed ID: 38660492
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identifying potential repurposable medications for Parkinson's disease through Mendelian randomization analysis.
    Wang Q; Liu F; Wang X; Zhong L; Cai B; Chen T
    Sci Rep; 2024 Aug; 14(1):19670. PubMed ID: 39181920
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mendelian Randomization Using the Druggable Genome Reveals Genetically Supported Drug Targets for Psychiatric Disorders.
    Li X; Shen A; Zhao Y; Xia J
    Schizophr Bull; 2023 Sep; 49(5):1305-1315. PubMed ID: 37418754
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mendelian Randomisation Finds No Causal Association between Urate and Parkinson's Disease Progression.
    Coneys R; Storm CS; Kia DA; Almramhi M; Wood NW
    Mov Disord; 2021 Sep; 36(9):2182-2187. PubMed ID: 34056740
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A Mendelian randomization study investigating the causal role of inflammation on Parkinson's disease.
    Bottigliengo D; Foco L; Seibler P; Klein C; König IR; Del Greco M F
    Brain; 2022 Oct; 145(10):3444-3453. PubMed ID: 35656776
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Parkinson's Disease Mendelian Randomization Research Portal.
    Noyce AJ; Bandres-Ciga S; Kim J; Heilbron K; Kia D; Hemani G; Xue A; Lawlor DA; Smith GD; Duran R; Gan-Or Z; Blauwendraat C; Gibbs JR; ; Hinds DA; Yang J; Visscher P; Cuzick J; Morris H; Hardy J; Wood NW; Nalls MA; Singleton AB
    Mov Disord; 2019 Dec; 34(12):1864-1872. PubMed ID: 31659794
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mendelian Randomization - the Key to Understanding Aspects of Parkinson's Disease Causation?
    Noyce AJ; Nalls MA
    Mov Disord; 2016 Apr; 31(4):478-83. PubMed ID: 26695521
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sleep behaviors and Parkinson's disease: A bidirectional Mendelian randomization analysis.
    Ling Y; Zhu J; Yan F; Tse LA; Kinra S; Jiang M
    Behav Brain Res; 2023 Mar; 441():114281. PubMed ID: 36608706
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identifying drug targets for neurological and psychiatric disease via genetics and the brain transcriptome.
    Baird DA; Liu JZ; Zheng J; Sieberts SK; Perumal T; Elsworth B; Richardson TG; Chen CY; Carrasquillo MM; Allen M; Reddy JS; De Jager PL; Ertekin-Taner N; Mangravite LM; Logsdon B; Estrada K; Haycock PC; Hemani G; Runz H; Smith GD; Gaunt TR;
    PLoS Genet; 2021 Jan; 17(1):e1009224. PubMed ID: 33417599
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Genetic Variants in Sulfonylurea Targets Affect Parkinson's Disease Risk: A Two-Sample Mendelian Randomization Study.
    Aziz NA; Wüllner U
    Mov Disord; 2023 Apr; 38(4):703-705. PubMed ID: 36782054
    [No Abstract]   [Full Text] [Related]  

  • 14. Visceral adipose tissue had a causal, independent role in lowering the risk of Parkinson's disease: A mendelian randomization study.
    Liu Y; Liu Q
    Parkinsonism Relat Disord; 2021 Nov; 92():51-52. PubMed ID: 34695655
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Low LDL cholesterol,
    Benn M; Nordestgaard BG; Frikke-Schmidt R; Tybjærg-Hansen A
    BMJ; 2017 Apr; 357():j1648. PubMed ID: 28438747
    [No Abstract]   [Full Text] [Related]  

  • 16. Identification of novel risk loci, causal insights, and heritable risk for Parkinson's disease: a meta-analysis of genome-wide association studies.
    Nalls MA; Blauwendraat C; Vallerga CL; Heilbron K; Bandres-Ciga S; Chang D; Tan M; Kia DA; Noyce AJ; Xue A; Bras J; Young E; von Coelln R; Simón-Sánchez J; Schulte C; Sharma M; Krohn L; Pihlstrøm L; Siitonen A; Iwaki H; Leonard H; Faghri F; Gibbs JR; Hernandez DG; Scholz SW; Botia JA; Martinez M; Corvol JC; Lesage S; Jankovic J; Shulman LM; Sutherland M; Tienari P; Majamaa K; Toft M; Andreassen OA; Bangale T; Brice A; Yang J; Gan-Or Z; Gasser T; Heutink P; Shulman JM; Wood NW; Hinds DA; Hardy JA; Morris HR; Gratten J; Visscher PM; Graham RR; Singleton AB; ; ;
    Lancet Neurol; 2019 Dec; 18(12):1091-1102. PubMed ID: 31701892
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Association between telomere length and Parkinson's disease: a Mendelian randomization study.
    Chen R; Zhan Y
    Neurobiol Aging; 2021 Jan; 97():144.e9-144.e11. PubMed ID: 32829966
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Based on systematic druggable genome-wide Mendelian randomization identifies therapeutic targets for diabetes.
    Li H; Li W; Li D; Yuan L; Xu Y; Su P; Wu L; Zhang Z
    Front Endocrinol (Lausanne); 2024; 15():1366290. PubMed ID: 38915894
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Plasma Caffeine Levels and Risk of Alzheimer's Disease and Parkinson's Disease: Mendelian Randomization Study.
    Larsson SC; Woolf B; Gill D
    Nutrients; 2022 Apr; 14(9):. PubMed ID: 35565667
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Genetic analysis of Mendelian mutations in a large UK population-based Parkinson's disease study.
    Tan MMX; Malek N; Lawton MA; Hubbard L; Pittman AM; Joseph T; Hehir J; Swallow DMA; Grosset KA; Marrinan SL; Bajaj N; Barker RA; Burn DJ; Bresner C; Foltynie T; Hardy J; Wood N; Ben-Shlomo Y; Grosset DG; Williams NM; Morris HR
    Brain; 2019 Sep; 142(9):2828-2844. PubMed ID: 31324919
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 39.